Organization Overview
Alternative names
chromium tripicolinate (3 trials)
clonidine (catapres) (1 trial)
diethylpropion hydrochloride (tenuate) (1 trial)
epinephrine (levophed) (1 trial)
fluticasone (cutivate) (1 trial)
acetaminophen (tylenol) (3 trials)
alteplase (Activase) (2 trials)
amlodipine (norvasc) (1 trial)
atorvastatin (lipitor) (2 trials)
beractant (survanta) (1 trial)
bifidobacterium infantis (1 trial)
colfosceril palmitate (1 trial)
dalfampridine (ampyra) (1 trial)
dapagliflozin (farxiga) (1 trial)
dronabinol (marinol) (3 trials)
follitropin alfa (Gonal-F) (1 trial)
abaloparatide (tymlos) (1 trial)
adenovirus-5 encoding human adenylyl cyclase type 6 (1 trial)
amino acids (Freamine) (4 trials)
aminosalicylic acid (Paser) (2 trials)
betahistine mesilate (1 trial)
bupropion (wellbutrin) (3 trials)
carboplatin (paraplatin) (1 trial)
cisplatin (platinol) (2 trials)
clopidogrel (plavix) (1 trial)
docetaxel (taxotere) (2 trials)
dornase alfa (pulmozyme) (1 trial)
eflornithine (ornidyl) (1 trial)
humanised anti-cd22 antibody (1 trial)
isosorbide (isordil) (1 trial)
loratadine (claritin) (1 trial)
methylnaltrexone (relistor) (1 trial)
ondansetron (zofran) (1 trial)
oxaliplatin (eloxatin) (1 trial)
pazopanib (votrient) (1 trial)
prasugrel (effient) (2 trials)
acetylsalicylic acid (aspirin) (2 trials)
albuterol (proventil) (2 trials)
aluminum hydroxide (Gaviscon) (1 trial)
bazedoxifene (Duavee) (1 trial)
campylobacter jejuni strain bh-01-0142 (1 trial)
cis-diamminedichloroplatinum (1 trial)
conjugated equine estrogens (Premarin) (1 trial)
diltiazem (cardizem) (1 trial)
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (1 trial)
live, attenuated, dengue serotype 1, 2, 3, 4 virus (1 trial)
live oral poliovirus type 1, 2 and 3 (Trivalent oral polio vaccine - Sabin) (1 trial)
mecamylamine (inversine) (2 trials)
monovalent oral polio vaccines (mopv1) (MOPV1) (1 trial)
novel oral polio vaccine type 1 (nopv1) (1 trial)
acetylcysteine (mucomyst) (1 trial)
blueberry allergenic extract (2 trials)
budesonide (rhinocort) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (1 trial)
eszopiclone (lunesta) (1 trial)
ethinyl estradiol (Estinyl) (1 trial)
ferumoxytol (feraheme) (1 trial)
Acute Lung Injury (Phase 2)
Alzheimer Disease (Phase 3)
Angina Pectoris (Phase 3)
Anterior Cruciate Ligament Injuries (Phase 3)
Asthma (Phase 4)
Atrophic Vaginitis (Phase 2)
Birth Weight (Phase 3)
Blood Coagulation Disorders (Phase 3)
Body Weight (Phase 3)
Breast Neoplasms (Phase 3)
Bronchopulmonary Dysplasia (Phase 3)
Campylobacter Infections (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiovascular Diseases (Phase 3)
Central Nervous System Neoplasms (Phase 1)
Cocaine-Related Disorders (Phase 2)
Cognitive Dysfunction (Phase 3)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Constipation (Phase 2)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Coronavirus Infections (Phase 3)
Cough (Phase 4)
Critical Illness (Phase 2)
Cystic Fibrosis (Phase 2)
Dengue (Phase 2)
Depression (Phase 3)
Depressive Disorder (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diarrhea (Phase 3)
Disease (Phase 2)
Dyspareunia (Phase 2)
Emergencies (Phase 4)
Fibrosis (Phase 2)
Glioblastoma (Phase 1)
Head and Neck Neoplasms (Phase 2)
Heart Diseases (Phase 3)
Heart Failure (Phase 2)
Hemorrhagic Fevers, Viral (Phase 1)
Hemostatic Disorders (Phase 3)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Hypersensitivity (Phase 3)
Hypertension (Phase 3)
Impulsive Behavior (Phase 4)
Infarction (Phase 3)
Infections (Phase 3)
Infertility (Phase 3)
Insulin Resistance (Phase 3)
Intestinal Diseases (Phase 3)
Ischemia (Phase 3)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lipoma (Phase 2)
Lung Injury (Phase 2)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Marijuana Abuse (Phase 1)
Memory Disorders (Phase 1)
Mental Disorders (Phase 1)
Mood Disorders (Phase 2)
Multiple Sclerosis (Phase 3)
Muscle Weakness (Phase 2)
Myasthenia Gravis (Phase 2)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 3)
Nausea (Phase 3)
Nervous System Neoplasms (Phase 1)
Neuroblastoma (Phase 2)
Obesity (Phase 4)
Opioid-Related Disorders (Phase 2)
Overweight (Phase 3)
Pain, Postoperative (Phase 4)
Parkinson Disease (Phase 4)
Poliomyelitis (Phase 1)
Polycystic Ovary Syndrome (Phase 4)
Polyradiculoneuropathy (Phase 3)
Psychotic Disorders (Phase 1)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 4)
Respiratory Distress Syndrome (Phase 3)
Respiratory Distress Syndrome, Newborn (Phase 3)
Respiratory Insufficiency (Phase 2)
Rhinitis (Phase 4)
Rotator Cuff Injuries (Phase 2)
Rotavirus Infections (Phase 4)
Sarcoma (Phase 2)
Schizophrenia (Phase 1)
Sclerosis (Phase 3)
Sepsis (Phase 1)
Severe Acute Respiratory Syndrome (Phase 3)
Severe Dengue (Phase 1)
Shock (Phase 1)
Sinusitis (Phase 4)
Sprue, Tropical (Phase 3)
Substance-Related Disorders (Phase 2)
Syndrome (Phase 3)
Thromboembolism (Phase 3)
Thrombosis (Phase 2)
Tobacco Use Disorder (Phase 2)
Ulcer (Phase 2)
Vaginitis (Phase 2)
Venous Thromboembolism (Phase 3)
Venous Thrombosis (Phase 2)
Vitamin D Deficiency (Phase 4)
Vomiting (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)
Wounds and Injuries (Phase 2)
Zika Virus Infection (Phase 1)